Table 1.
Patient demographics and treatments pursued
| Used tool (N = 255)a |
Did not use tool (N = 35)a |
Total (N = 290)a |
|
|---|---|---|---|
| Age in years (mean [SD]) | 56.8 (11.8) | 60.6 (12.0) | 57.2 (11.8) |
| Race | |||
| White | 236 (92.5%) | 31 (88.6%) | 267 (92.1%) |
| African American | 1 (0.4%) | 1 (2.9%) | 2 (0.7%) |
| American Indian/Alaskan Native | 4 (1.6%) | 0 (0.0%) | 4 (1.4%) |
| Asian | 7 (2.7%) | 2 (5.7%) | 9 (3.1%) |
| Other | 2 (0.8%) | 0 (0.0%) | 2 (0.7%) |
| Unknown or choose not to disclose | 5 (2.0%) | 1 (2.9%) | 6 (2.1%) |
| Education | |||
| Some high school (HS), did not graduate | 1 (0.4%) | 0 (0.0%) | 1 (0.3%) |
| HS graduate or GED | 35 (13.8%) | 12 (35.3%) | 47 (16.3%) |
| Some college or 2-year degree | 81 (31.9%) | 8 (23.5%) | 89 (30.9%) |
| 4-year college graduate | 69 (27.2%) | 8 (23.5%) | 77 (26.7%) |
| Post graduate studies | 68 (26.8%) | 6 (17.6%) | 74 (25.7%) |
| Preferred decision making approach | |||
| I make decision | 5 (2.2%) | 3 (8.6%) | 8 (3.0%) |
| I make decision & consider doctor’s opinion | 68 (29.4%) | 11 (31.4%) | 79 (29.7%) |
| Shared decision making | 144 (62.3%) | 18 (51.4%) | 162 (60.9%) |
| Doctor makes decision & considers my opinion | 11 (4.8%) | 3 (8.6%) | 14 (5.3%) |
| Doctor makes decision | 3 (1.3%) | 0 (0.0%) | 3 (1.1%) |
| Breast cancer stage | |||
| Stage 0 | 35 (16.2%) | 3 (12.0%) | 38 (15.8%) |
| Stage I | 97 (44.9%) | 13 (52.0%) | 110 (45.6%) |
| Stage II | 66 (30.6%) | 5 (20.0%) | 71 (29.5%) |
| Stage III | 18 (8.3%) | 4 (16.0%) | 22 (9.1%) |
| Breast cancer laterality | |||
| Bilateral | 11 (4.9%) | 4 (14.8%) | 15 (5.9%) |
| Unilateral | 215 (95.1%) | 23 (85.2%) | 238 (94.1%) |
| Breast cancer type | |||
| Bilateral (discordant) | 6 (2.7%) | 1 (3.7%) | 7 (2.8%) |
| Ductal carcinoma in situ | 39 (17.3%) | 3 (11.1%) | 42 (16.7%) |
| Invasive | 180 (80.0%) | 23 (85.2%) | 203 (80.6%) |
| Hormonal therapyb | |||
| Adjuvant | 139/226 (61.5%) | 17/27 (63.0%) | 156/253 (61.7%) |
| Neoadjuvant | 13/226 (5.8%) | 0/27 (0.0%) | 13/253 (5.1%) |
| Chemotherapyb | |||
| Adjuvant | 36/226 (15.9%) | 6/27 (22.2%) | 42/253 (16.6%) |
| Neoadjuvant | 13/226 (5.8%) | 0/27 (0.0%) | 13/253 (5.1%) |
| Radiation therapyb | 133/226 (58.8%) | 18/27 (66.7%) | 151/253 (59.7%) |
| Surgeryb | |||
| Lumpectomy | 123/226 (54.4%) | 14/27 (51.9%) | 137/253 (54.2%) |
| Unilateral mastectomy | 44/226 (19.5%) | 4/27 (14.8%) | 48/253 (19.0%) |
| Bilateral mastectomy | 59/226 (26.1%) | 8/27 (29.6%) | 67/253 (26.5%) |
| Reconstructive surgery | 75/226 (33.2%) | 6/27 (22.2%) | 81/253 (32.0%) |
aFrequencies not adding to column total indicate missing data (not included in denominator for percentages)
bCategories not mutually exclusive (denominators provided)